Index of artpub/2024/pmc_10891028/

Reich, Kristian
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab : A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
2024
https://ddd.uab.cat/record/291410